Comparing two surgical methods for treating enlarged prostate
Official title: Bipolar Trans Urethral Resection of the Prostate (TURP) Versus Bipolar Enucleation of the Prostate in Treatment of Benign Prostatic Hyperplasia (BPH): A Prospective Randomized Comparative Clinical Study
Run by South Valley University · NCT06983444 · Data updated 2026-11-12
This study is testing two different surgical methods for treating an enlarged prostate to see which one is safer and more effective for men with urinary problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | Men only |
| Enrollment | 100 (estimated) |
| Sponsor | South Valley University Academic / other |
| Locations | 1 site (Qina, Qena Governorate) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | July 2026 |
| Registry record updated | May 21, 2025 |
| Trial ID | NCT06983444 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men aged 50-80 with lower urinary tract symptoms due to BPH and specific urinary flow rate and prostate volume criteria.
✕Probably not a fit
Patients with prostate or bladder cancer, urethral stricture, or neurogenic bladder may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the efficacy and safety of two surgical techniques for managing benign prostatic hyperplasia (BPH): transurethral resection of the prostate (TURP) and bipolar enucleation of the prostate (TUEP). TURP has been the traditional gold standard but carries significant risks and complications, while TUEP is a minimally invasive alternative that may offer similar effectiveness with fewer complications. The study aims to compare these two approaches to determine their true benefits and safety profiles. Patients with lower urinary tract symptoms due to BPH will be enrolled based on specific eligibility criteria.
Why it matters
Potential benefit: If successful, this study could provide a safer and more effective surgical option for patients suffering from BPH.
How similar studies have gone: Previous studies have shown promising results for minimally invasive approaches like bipolar enucleation, indicating potential success for this comparison.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with lower urinary tract symptoms (LUTS) due to BPH. 2. Patients with international prostate score system (IPSS) more than 8. 3. Patients with maximal urinary flow rate (Qmax) less than 10ml/second. 4. Patients with Prostatic volume (60 - 100 gm). 5. Patient with indication for surgical intervention. 6. Patient age (50-80 years old) Exclusion Criteria: 1. Prostatic cancer. 2. Bladder cancer. 3. Urethral stricture. 4. Neurogenic bladder.
Where it's running
-
Faculty of Medicine South Valley University
Qina, Qena Governorate, Egypt Recruiting
Study contacts
- Study coordinator: AHMED A.FATAH HAMED, Master's
- Email: ahmeda.hamed1991@med.svu.edu.eg
- Phone: 00201146085302
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tri-lobar HoLEP vs En-bloc HoLEP: learning curves in men with enlarged prostates
This study tests whether the tri-lobar or en-bloc HoLEP technique is easier to learn for surgeons new to HoLEP in men with BPH and prostate sizes 80–150 cc.
-
Rezum versus prostatic artery embolization for relieving urinary symptoms from BPH
This study will test whether Rezum (water vapor therapy) or prostatic artery embolization works better at reducing bothersome urinary symptoms in men with moderate-to-severe BPH.
-
Examining the link between urine proteins and urinary symptoms in men with prostate enlargement
This study is testing how certain proteins in urine relate to urinary problems in older men with prostate enlargement and whether a specific surgery can help improve their symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.